Hong Fang Song, Director at CG Oncology, Inc. (CGON), sold 130,105 shares at $27.60 ($3.6M) on 2025-09-03, disclosed to the SEC on 2025-09-04.
Scheduled sale ($3.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.60 | 69,695 | $1.9M | 53.0% |
| 2 | $28.24 | 30,105 | $850K | 23.4% |
| 3 | $28.24 | 30,105 | $850K | 23.4% |
| 4 | $28.96 | 100 | $3K | 0.1% |
| 5 | $28.99 | 100 | $3K | 0.1% |
| Total | $27.90 avg | 130,105 |
| $3.6M |
| 100% |
| Filing → |
| CGON | BUY | 2024-01-31 | $5.0M | — | Filing → |